Marvin Hausman

Marvin Hausman

Net worth: 397 595 $ as of 2026-09-29

84 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Marvin S.
Hausman
, MD, is a Chairman & Chief Executive Officer at Total Nutraceutical Solutions, Inc., a President at Northwest Medical Research Partners, Inc., a Chief Scientific Officer at Ludwig Enterprises, Inc., a Chairman at SwabAi Diagnostics, Inc., a Chief Scientific Officer at Xycota Biosciences LLC and an Independent Director at NuGenerex Immuno-Oncology, Inc. He is on the Board of Directors at NuGenerex Immuno-Oncology, Inc. Dr. Hausman was previously employed as a Chief Scientific Officer by Lion Biotechnologies, Inc., a Chairman, Chief Science & Technology Officer by Entia Biosciences, Inc., a Chairman, President & Chief Executive Officer by OXIS International, Inc., a Chairman, President & Chief Executive Officer by Axonyx, Inc., a Member-Governors Board by New York University, a Member by American Association for the Advancement of Science, a Member by American Board of Urology, a Member by American College of Surgeons, a Member by American Federation for Medical Research, a Member by American Medical Association, a Member by American Urological Association Education & Research, Inc., a Member by Association for Academic Surgery, a Member by California Medical Association, a Co-Founder by King Pharmaceuticals Research & Development, Inc., a Research Associate by National Institutes of Health, a Member by New York Academy of Sciences, a Member by The American Association of Immunologists, a Member by The Royal Society of Medicine, and a Chairman & Chief Executive Officer by W World Corp.
He also served on the board at Arbios Technologies, Inc., OXIS International, Inc., Regent Assisted Living, Inc., TorreyPines Therapeutics, Inc. and Arbios Systems, Inc. He received his undergraduate degree from Brooklyn College and a doctorate degree from New York University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-28 37,758,000 ( 22.59% ) 377 580 $ 2026-09-29
2025-06-15 2,000,000 ( 28.57% ) 20 000 $ 2026-09-29
2017-05-07 14,625 ( -.--% ) 15 $ 2026-09-29

Marvin Hausman active positions

CompaniesPositionStart
NUGENEREX IMMUNO-ONCOLOGY, INC. Director/Board Member -
LUDWIG ENTERPRISES, INC. Founder 1988-02-10
Chairman -
Chief Executive Officer 2008-09-30
Northwest Medical Research Partners, Inc.
Founder 1995-09-30

Former positions of Marvin Hausman

CompaniesPositionEnd
IOVANCE BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2013-09-25
GT BIOPHARMA, INC. Director of Finance/CFO -
Director/Board Member 2007-05-22
Chief Executive Officer 2006-10-05
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Marvin Hausman's experience

Education of Marvin Hausman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

85

1st degree connections

30

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies30

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Government

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Northwest Medical Research Partners, Inc.

Commercial Services

Finance

Commercial Services

Association for Academic Surgery

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Marvin Hausman